181 related articles for article (PubMed ID: 19100399)
1. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation.
Taber DJ; Weimert NA; Henderson F; Lin A; Bratton CF; Chavin KD; Baliga PK
Transplant Proc; 2008 Dec; 40(10):3401-7. PubMed ID: 19100399
[TBL] [Abstract][Full Text] [Related]
2. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
[TBL] [Abstract][Full Text] [Related]
3. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.
Sampaio MS; Kadiyala A; Gill J; Bunnapradist S
Transplantation; 2009 Oct; 88(7):904-10. PubMed ID: 19935462
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation.
Hammond EB; Taber DJ; Weimert NA; Egidi MF; Bratton CF; Lin A; McGillicuddy JW; Chavin KD; Baliga PK
Clin Transplant; 2010; 24(1):40-7. PubMed ID: 19236436
[TBL] [Abstract][Full Text] [Related]
5. Induction therapy in pediatric kidney transplant recipients discharged with a triple drug immunosuppressive regimen.
Sampaio MS; Poommipanit N; Kuo HT; Reddy PN; Cho YW; Shah T; Bunnapradist S
Pediatr Transplant; 2010 Sep; 14(6):770-8. PubMed ID: 20477974
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function.
Chen G; Gu J; Qiu J; Wang C; Fei J; Deng S; Li J; Huang G; Fu Q; Chen L
Exp Clin Transplant; 2013 Aug; 11(4):310-4. PubMed ID: 23121641
[TBL] [Abstract][Full Text] [Related]
7. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
[TBL] [Abstract][Full Text] [Related]
8. The role of anti-IL-2 receptor in high-risk kidney transplant patients.
Jirasiritham S; Sumethkul V; Mavichak V; Lertsithichai P; Jirasiritham S
Transplant Proc; 2004 Sep; 36(7):2110-2. PubMed ID: 15518764
[TBL] [Abstract][Full Text] [Related]
9. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
10. Induction immunotherapy with IL-2Ra monoclonal antibody in kidney transplantation.
Ahsan N
Minerva Urol Nefrol; 2003 Mar; 55(1):67-79. PubMed ID: 12773968
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
Lim WH; Chang SH; Chadban SJ; Campbell SB; Dent H; Russ GR; McDonald SP
Transplantation; 2009 Nov; 88(10):1208-13. PubMed ID: 19935375
[TBL] [Abstract][Full Text] [Related]
12. Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome.
Bazerbachi F; Selzner M; Boehnert MU; Marquez MA; Norgate A; McGilvray ID; Schiff J; Cattral MS
Transplantation; 2011 Nov; 92(9):1039-43. PubMed ID: 22002345
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-2 receptor antagonists on new-onset diabetes after liver transplantation: A retrospective cohort study.
Xue M; Lv C; Chen X; Huang X; Sun Q; Wang T; Liang J; Zhang Y; He S; Gao J; Zhou J; Yu M; Fan J; Gao X
J Diabetes; 2016 Jul; 8(4):579-87. PubMed ID: 26588180
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results.
Hardinger KL; Rhee S; Buchanan P; Koch M; Miller B; Enkvetchakul D; Schuessler R; Schnitzler MA; Brennan DC
Transplantation; 2008 Oct; 86(7):947-52. PubMed ID: 18852661
[TBL] [Abstract][Full Text] [Related]
15. Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients.
Gabardi S; Catella J; Martin ST; Perrone R; Chandraker A; Magee CC; McDevitt-Potter LM
Ann Pharmacother; 2011 Sep; 45(9):e48. PubMed ID: 21811001
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death.
Peng W; Liu G; Xie W; Huang H; Wu J; Shou Z; Chen J
Int J Clin Pract Suppl; 2015 May; (183):23-8. PubMed ID: 26177071
[TBL] [Abstract][Full Text] [Related]
17. Induction Immunosuppressive Therapy Use in Deceased Donor Kidney Transplantation: 11-Year Experience in Veracruz, Mexico.
Martinez-Mier G; Soto-Miranda E; Avila-Pardo SF; Budar-Fernandez LF; Mateu-Rivera LJ; Mendez-Lopez MT; Trujillo-Martinez MF; Uscanga-Montesano A; Avila Y Falfan D
Transplant Proc; 2016 Mar; 48(2):600-4. PubMed ID: 27110011
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation.
Al Najjar A; Etienne I; Le Pogamp P; Bridoux F; Le Meur Y; Toupance O; Mousson C; Caillard S; Hurault de Ligny B; Marlière JF; Lebranchu Y
Transplant Proc; 2006 Sep; 38(7):2298-9. PubMed ID: 16980070
[TBL] [Abstract][Full Text] [Related]
19. Induction with basiliximab plus thymoglobulin is effective and safe in old-for-old renal transplantation: six-month results of a prospective clinical study.
Favi E; Gargiulo A; Spagnoletti G; Salerno MP; Silvestrini N; Valente I; Citterio F
Transplant Proc; 2010 May; 42(4):1114-7. PubMed ID: 20534237
[TBL] [Abstract][Full Text] [Related]
20. Induction treatment with low-dose thymoglobulin or basiliximab in renal transplants from older donors.
Gavela Martínez E; Sancho Calabuig A; Escudero Quesada V; Avila Bernabeu AI; Beltrán Catalán S; Morales García AI; Crespo Albiach JF; Pallardó Mateu LM
Transplant Proc; 2008 Nov; 40(9):2900-2. PubMed ID: 19010141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
